Year |
Citation |
Score |
2019 |
Guan Y, Tiwari AD, Phillips JG, Hasipek M, Grabowski D, Kerr CM, Adema V, Nagata Y, Visconte V, Radivoyevitch T, Lindner D, Meggendorfer M, Abazeed M, Sekeres MA, Haferlach T, et al. TET Dioxygenase Inhibition As a Therapeutic Strategy in TET2 Mutant Myeloid Neoplasia Blood. 134: 880-880. DOI: 10.1182/Blood-2019-131920 |
0.33 |
|
2017 |
De M, Oleskie AN, Ayyash M, Dutta S, Mancour L, Abazeed ME, Brace EJ, Skiniotis G, Fuller RS. The Vps13p-Cdc31p complex is directly required for TGN late endosome transport and TGN homotypic fusion. The Journal of Cell Biology. PMID 28122955 DOI: 10.1083/Jcb.201606078 |
0.658 |
|
2017 |
Koshkin VS, Reynolds J, Elson P, Magi-Galluzzi C, McKenney J, Smith KS, Shadrach B, Isse K, Saunders LR, Hu M, Tendulkar RD, Stephenson AJ, Fergany AF, Abazeed M, Rini BI, et al. Molecular profiling of small cell bladder cancer (SCBC) to reveal gene expression determinants of an aggressive phenotype. Journal of Clinical Oncology. 35: 4529-4529. DOI: 10.1200/Jco.2017.35.15_Suppl.4529 |
0.302 |
|
2017 |
Grivas P, Koshkin VS, Pettiford J, Atkins L, Elson P, Reynolds J, Magi-Galluzzi C, McKenney J, Isse K, Saunders LR, Hu M, Fergany AF, Haber GP, Garcia JA, Rini B, ... ... Abazeed M, et al. Poster ViewingMolecular Profiling of Small Cell Bladder Cancer Reveals Gene Expression Determinants of an Aggressive Phenotype International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.1211 |
0.326 |
|
2016 |
Sohal DP, Shrotriya S, Abazeed M, Cruise M, Khorana A. Molecular characteristics of biliary tract cancer. Critical Reviews in Oncology/Hematology. 107: 111-118. PMID 27823638 DOI: 10.1016/J.Critrevonc.2016.08.013 |
0.305 |
|
2016 |
Kim JW, Botvinnik OB, Abudayyeh O, Birger C, Rosenbluh J, Shrestha Y, Abazeed ME, Hammerman PS, DiCara D, Konieczkowski DJ, Johannessen CM, Liberzon A, Alizad-Rahvar AR, Alexe G, Aguirre A, et al. Characterizing genomic alterations in cancer by complementary functional associations. Nature Biotechnology. PMID 27088724 DOI: 10.1038/Nbt.3527 |
0.435 |
|
2016 |
Huynh MA, Maire CL, Abazeed M, Lam FC, Adams D, Pelton K, Pinnell N, Knoff DC, Korideck H, Hummelen PV, Thorner A, Wen PY, Ligon A, Floyd SR, Schreiber SL, et al. Functional profiling of a glioblastoma (GBM) patient-derived cell line (PDCL) panel to identify cell-intrinsic differential radiation response. Journal of Clinical Oncology. 34: 2069-2069. DOI: 10.1200/Jco.2016.34.15_Suppl.2069 |
0.475 |
|
2015 |
Abazeed M, Yard B, Adams D, Tamayo P, Hearn J, Chie EK, Schreiber S, Meyerson M, Peacock C, Hammerman P. Abstract 3315: Functional genomic profiling of lung adenocarcinoma identifies BRAF mutations as novel therapeutic targets Cancer Research. 75: 3315-3315. DOI: 10.1158/1538-7445.Am2015-3315 |
0.506 |
|
2015 |
Huynh M, Maire C, Abazeed M, Adams D, Pelton K, Pinnell N, Ramkissoon S, Korideck H, Van Hummelen P, Thorner A, Wen P, Ligon A, Schreiber S, Meyerson M, Ligon K, et al. Functional Profiling of a Glioblastoma (GBM) Patient-Derived Cell Line (PDCL) Panel Identifies Cell-Intrinsic Differential Radiation Response That Correlates With TP53 Mutations International Journal of Radiation Oncology*Biology*Physics. 93: E91-E92. DOI: 10.1016/J.Ijrobp.2015.07.779 |
0.475 |
|
2015 |
Abazeed M, Adams D, Hammerman P, Tamayo P, Yard B, Meyerson M, Schreiber S. Systematic Investigation of Genetic Vulnerabilities Across Cancer Cell Lines Reveals Lineage Specific Radiotherapeutic Determinants International Journal of Radiation Oncology*Biology*Physics. 93: S143-S144. DOI: 10.1016/J.Ijrobp.2015.07.340 |
0.476 |
|
2014 |
Abazeed M, Adams D, Tamayo P, Meyerson M, Hammerman P, Schreiber S. Abstract 4259: The radiogenomic landscape of cancer Cancer Research. 74: 4259-4259. DOI: 10.1158/1538-7445.Am2014-4259 |
0.488 |
|
2014 |
Abazeed M, Xu C, Adams D, Tamayo P, Loeffler J, Suh J, Meyerson M, Wong K, Hammerman P. NRF2 Is a Novel Oncogene and Biomarker of Therapeutic Resistance in Non-Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 90: S53. DOI: 10.1016/J.Ijrobp.2014.08.252 |
0.469 |
|
2014 |
Abazeed M, Xu C, Adams D, Tamayo P, Loeffler J, Suh J, Meyerson M, Wong K, Hammerman P. NRF2 Is a Novel Oncogene and Biomarker of Therapeutic Resistance in Non-Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 90: S104-S105. DOI: 10.1016/J.Ijrobp.2014.05.516 |
0.47 |
|
2014 |
Abazeed M, Adams D, Tamayo P, Yard B, Loeffler J, Suh J, Meyerson M, Hammerman P, Schreiber S. The Radiogenomic Landscape of Cancer International Journal of Radiation Oncology*Biology*Physics. 90: S34. DOI: 10.1016/J.Ijrobp.2014.05.145 |
0.434 |
|
2013 |
Abazeed ME, Adams DJ, Hurov KE, Tamayo P, Creighton CJ, Sonkin D, Giacomelli AO, Du C, Fries DF, Wong KK, Mesirov JP, Loeffler JS, Schreiber SL, Hammerman PS, Meyerson M. Integrative radiogenomic profiling of squamous cell lung cancer. Cancer Research. 73: 6289-98. PMID 23980093 DOI: 10.1158/0008-5472.Can-13-1616 |
0.441 |
|
2013 |
De M, Abazeed ME, Fuller RS. Direct binding of the Kex2p cytosolic tail to the VHS domain of yeast Gga2p facilitates TGN to prevacuolar compartment transport and is regulated by phosphorylation. Molecular Biology of the Cell. 24: 495-509. PMID 23408788 DOI: 10.1091/mbc.E12-11-0843 |
0.604 |
|
2012 |
Abazeed M, Hammerman P, Creighton C, Adams D, Giacomelli A, Meyerson M. NRF2 Pathway Activation Regulates Radiation Resistance in Lung Squamous Cell Carcinoma International Journal of Radiation Oncology*Biology*Physics. 84: S179-S180. DOI: 10.1016/J.Ijrobp.2012.07.465 |
0.38 |
|
2012 |
Abazeed M, Adams D, Giacomelli A, Pashtan I, Hammerman P, Meyerson M. Development of a High Throughput Platform for Measuring Radiation Response International Journal of Radiation Oncology*Biology*Physics. 84: S701. DOI: 10.1016/J.Ijrobp.2012.07.1874 |
0.336 |
|
2008 |
Abazeed ME, Fuller RS. Yeast Golgi-localized, gamma-Ear-containing, ADP-ribosylation factor-binding proteins are but adaptor protein-1 is not required for cell-free transport of membrane proteins from the trans-Golgi network to the prevacuolar compartment. Molecular Biology of the Cell. 19: 4826-36. PMID 18784256 DOI: 10.1091/mbc.E07-05-0442 |
0.663 |
|
2005 |
Abazeed ME, Blanchette JM, Fuller RS. Cell-free transport from the trans-golgi network to late endosome requires factors involved in formation and consumption of clathrin-coated vesicles. The Journal of Biological Chemistry. 280: 4442-50. PMID 15572353 DOI: 10.1074/Jbc.M412553200 |
0.704 |
|
2004 |
Blanchette JM, Abazeed ME, Fuller RS. Cell-free reconstitution of transport from the trans-golgi network to the late endosome/prevacuolar compartment. The Journal of Biological Chemistry. 279: 48767-73. PMID 15364946 DOI: 10.1074/Jbc.M406368200 |
0.708 |
|
Show low-probability matches. |